Last updated on March 2018

Metastasectomy Study in Renal Cell Carcinoma (RCC)


Brief description of study

The goal of this clinical research study is to learn if the surgical removal of your primary tumor or the parts of the cancer that has spread to other parts of the body is a good method for treating patients who have kidney cancer. Only the parts of the cancer that has spread will be removed during the surgery.

Detailed Study Description

This research study is designed to follow your progress after the surgery is complete. You will not receive any drugs or treatment as part of this research study. You may however receive non-study treatment after your surgery.

Study Visits:

Every 6 months for 5 years after surgery, the following tests and procedures will be

performed
  • You will have a physical exam, including measurement of your weight and vital signs.
  • Your performance status will be recorded.
  • Blood (about 2-3 teaspoons) and urine will be collected for routine tests.
  • You will have CT scans or MRI scans of your chest, stomach area, and brain to check the status of the disease.
  • If the study doctor thinks it is necessary, you will have a bone scan to check the status of the disease.

Length of Study:

You will have study visits for up to 5 years after the surgery is complete. You will be taken off study early if the disease gets worse, or if the study doctor thinks that it is no longer in your best interest to continue.

Long-Term Follow-Up:

About every 6 months after your last study visit, the study staff will either review your medical records or contact you by phone or email to collect information about your health, to see how you are doing, and what anti-cancer treatments you may have received. If you are contacted by phone, the call should only last about 5 minutes each time.

This is an investigational study. Up to 120 patients will take part in this study. All will be enrolled at MD Anderson.

Clinical Study Identifier: NCT00918775

Contact Investigators or Research Sites near you

Start Over

Eric Jonasch, MD

University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »